Indications for use of anti-GM1 Antibodies ELISA

Anti-GM1 Antibodies ELISA is a valuable tool for detecting and quantifying anti-GM1 antibodies, offering advantages such as sensitivity, specificity, and objectivity. It is indicated in various clinical and research contexts, primarily for diagnosing neuropathic conditions like Guillain-Barré Syndrome (GBS; predominately IgG mediated) and Multifocal Motor Neuropathies (MMN; predominately IgM mediated).

Measuring anti-GM1 antibodies using Enzyme-Linked Immunosorbent Assay (ELISA) offers several advantages and indications:

  1. High Sensitivity: ELISA is a highly sensitive method, capable of detecting even low levels of anti-GM1 antibodies in patient samples.
  2. Quantitative Results: ELISA provides quantitative results, allowing for precise measurement of antibody levels, which can be valuable for disease monitoring and research.
  3. Specificity: ELISA can be designed to specifically detect anti-GM1 antibodies, reducing the likelihood of false-positive results due to cross-reactivity with other antibodies.
  4. Objective Results: ELISA results are objective and reproducible, minimizing the potential for human error in interpretation.


anti-GM1 Antibodies ELISA Product Information

Method ELISA
Time to Result 4.5 h (approx.)
Sample Type 20 µl serum (1:50)
Standard Range quantitative
Isotypes IgG and IgM
Order Code EK-GM1-GM